Sep 12, 2023 / 05:35PM GMT
Tejas Rajeev Savant - Morgan Stanley, Research Division - Equity Analyst
All right. Good afternoon, everyone. My name is Tejas Savant, I'm the life science tools and diagnostics analyst here at Morgan Stanley. Before we begin, for important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, do reach out to your sales rep.
So it's my great pleasure this afternoon to host Olink. And from the company, we have Carl Raimond, President; and Oskar Hjelm, CFO. So thank you both for doing this.
Carl Raimond - Olink Holding AB(publ)-President
Thank you for having us.
Questions and Answers:
Tejas Rajeev Savant - Morgan Stanley, Research Division - Equity AnalystMaybe, Carl, to set the stage, can you just discuss what you view as your key accomplishments over the past 6 to 12 months? And what do you view as the most important opportunities in those rolling heading into 2024?